Exponent, Inc. (NASDAQ:EXPO) insider Harri Kytomaa sold 2,000 shares of the firm’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $70.09, for a total value of $140,180.00. Following the sale, the insider now directly owns 9,399 shares of the company’s stock, valued at approximately $658,775.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of NASDAQ EXPO traded up $0.16 during trading on Friday, reaching $70.21. The stock had a trading volume of 1,188 shares, compared to its average volume of 240,012. Exponent, Inc. has a fifty-two week low of $44.44 and a fifty-two week high of $70.92. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.60 and a current ratio of 3.60. The business’s 50-day moving average price is $64.37 and its 200-day moving average price is $58.37. The company has a market cap of $3.65 billion, a P/E ratio of 56.41 and a beta of 0.43.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, July 18th. The business services provider reported $0.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.33 by $0.06. Exponent had a return on equity of 23.44% and a net margin of 19.64%. The business had revenue of $106.50 million during the quarter, compared to analysts’ expectations of $95.77 million. During the same period in the previous year, the firm posted $0.34 earnings per share. The company’s revenue was up 11.4% on a year-over-year basis. Analysts forecast that Exponent, Inc. will post 1.47 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Friday, September 6th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Thursday, September 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.91%. Exponent’s payout ratio is presently 51.20%.
Several hedge funds and other institutional investors have recently modified their holdings of EXPO. Nuveen Asset Management LLC acquired a new stake in shares of Exponent in the second quarter valued at $34,946,000. Norges Bank acquired a new position in Exponent during the 4th quarter worth $27,435,000. FMR LLC grew its stake in Exponent by 39.8% during the 1st quarter. FMR LLC now owns 993,288 shares of the business services provider’s stock worth $57,333,000 after purchasing an additional 282,530 shares in the last quarter. Morgan Stanley grew its stake in Exponent by 82.4% during the 2nd quarter. Morgan Stanley now owns 359,112 shares of the business services provider’s stock worth $21,023,000 after purchasing an additional 162,208 shares in the last quarter. Finally, Conestoga Capital Advisors LLC grew its stake in Exponent by 4.4% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock worth $141,785,000 after purchasing an additional 102,845 shares in the last quarter. 88.68% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have recently weighed in on EXPO. Zacks Investment Research raised Exponent from a “hold” rating to a “strong-buy” rating and set a $76.00 price objective for the company in a research note on Monday, July 22nd. SunTrust Banks set a $70.00 price objective on Exponent and gave the company a “buy” rating in a research note on Friday, July 19th. ValuEngine cut Exponent from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. William Blair reaffirmed a “market perform” rating on shares of Exponent in a research note on Monday, April 22nd. Finally, Cantor Fitzgerald lifted their price objective on Exponent from $64.00 to $73.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. One analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Exponent presently has a consensus rating of “Buy” and an average price target of $73.00.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.